Helen Scharfman Co-authors Four Papers in Four Weeks; One Paper Highlighted as Editor’s Choice
New York – The month of November saw the publishing of two papers co-authored by Dr. Helen Scharfman, head of the Scharfman Lab at the Center for Dementia Research. The first paper, titled “Epigenetic suppression of hippocampal calbindin-D28k by ΔFosB drives seizure-related cognitive deficits,” appears in Nature Medicine. The same paper is highlighted as an Editors’ Choice selection in the November 22 issue of Science Translational Medicine, featuring an article called “The vicious epigenetic cycle of neuronal activation.” The second paper, appearing in the November issue of Epilepsia, is titled “Common data elements for preclinical epilepsy research: Standards for data collection and reporting. A TASK3 report of the AES/ILAE Translational Task Force of the ILAE.” Dr. Scharfman preceded these two papers with two more publications in late October, bringing her total to four papers co-authored and published in less than 30 days. The October papers, both published in Epilepsy & Behavior, are titled “Epilepsy as a Network Disorder (1): What can we learn from other network disorders such as autistic spectrum disorder and mood disorders?” and “Epilepsy as a Network Disorder (2): What can we learn from other network disorders such as dementia and schizophrenia, and what are the implications for translational research?”